Revues phares et communiqués de presse
-
9 November 2021
-
Cochrane Skin is pleased to announce the publication of a new review, Phototherapy for atopic eczema. This review was led by dermatologists from Amsterdam University Medical Centers, and supported by a key stakeholder: the American Academy of Dermatology (AAD). The AAD provided funding for this systematic review (32 studies, 1219 people with...4 November 2021
-
1 November 2021
-
1 November 2021
-
1 November 2021
-
This recently published Cochrane Review, published by Cochrane Effective Practice and Organisation of Care, explores how parents and carers make decisions regarding vaccinating their children. Cochrane EPOC have also produced a short implementation guide related to this review. Key messages Many factors influence parents’ vaccination views and...27 octobre 2021
-
22 octobre 2021
-
21 octobre 2021
-
Is colchicine an effective treatment for people with COVID-19? Colchicine was debated to be a potential treatment option for COVID-19, hoping that the medication’s anti-inflammatory properties could prevent or reduce a dysregulated immune response.Although there are completed studies without publication and diverse ongoing studies that could...18 octobre 2021
-
In this interview with Doctoral Researcher Rebecca Dean and Professor Andrea Cipriani we learn more about two reviews investigating the use of ketamine as a treatment for depression recently published through Cochrane’s Common Mental Disorders Group. Tell us about this Cochrane ReviewThis review is an update of a Cochrane review published in 2015...11 octobre 2021
Pages
- « première
- ‹ précédente
- …
- 7
- 8
- 9
- 10
- 11
- 12
- 13
- 14
- 15
- …
- suivante ›
- dernière »
Les traductions sur ce site ont été rendues possibles grâce à la contribution financière du Ministère français des affaires sociales et de la santé et des instituts publics de recherche canadiens.